Meet Arpeggio Biosciences

Who we are

Dedicated to making medicine

Arpeggio is a team of computer scientists, biologists, and entrepreneurs using functional genomics to find new therapeutic targets for hard to treat diseases like cancer. We believe that building tomorrow’s medicines will require an integrated perspective that combines ideas and methods from disparate scientific fields. Our team and the work we do directly reflects this multidisciplinary approach.

Our team

Ardeshir Goliaei, PhD
Computational Chemist
Carter Grochala
Sr. Research Associate
Dave Simpson
Lab Operations Manager
Jeff Hsu
Automation Engineer
Jenna Rimel, PhD
Sr. Scientist
Joey Azofeifa, PhD
CEO & Co-founder
Kevin Eastwood
Chief Business Officer
Laura Norris
COO & Co-founder
Leah Damon, PhD
Sr. Scientist
Reo Yoo, MS
Sr. Research Associate
Richard Steel, PhD
Sr. Medicinal Chemist
Tim Read, PhD
CTO & Co-founder

Our advisors

Amit Mehta, MD, FRCP

Board Director

Builders VC

Joe McMahon

Strategic Advisor

KBI Biopharma

John Dickson, PhD

Medicinal Chemistry

Bristol Myers Squibb

David Wurtman, MD, MBA

Business Development

Lyric Pharma

Robin Dowell, PhD

Scientific Advisor

Biofrontiers Institute

Dave Morris, PhD

Automation Advisor

Precision BioSciences, GSK

Robert Kramer, PhD

Oncology Advisor

Portage Biotech, J&J

Bill Barrett

WSGR Counsel
GRAIL, Illumina

Our investors

Join our team

Creativity and drive

We're always searching for highly driven scientists, executives, and engineers to join our team pushing the boundaries of medicine. Please reach out to us! 
View careers page